{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:13:27Z","timestamp":1782962007447,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.4065\/76.1.22","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:18:34Z","timestamp":1232759914000},"page":"22-28","source":"Crossref","is-referenced-by-count":106,"title":["A Long-term Retrospective Study of Young Women With Essential Thrombocythemia"],"prefix":"10.4065","volume":"76","author":[{"given":"Ayalew","family":"Tefferi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Clark","family":"Hoagland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/76.1.22_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I","article-title":"Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County study, 1976-1995","volume":"61","author":"Mesa","year":"1999","journal-title":"Am J Hematol"},{"key":"10.4065\/76.1.22_bib2","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","article-title":"Life expectancy of patients with chronic nonleukemic myeloproliferative disorders","volume":"67","author":"Rozman","year":"1991","journal-title":"Cancer"},{"issue":"suppl 1","key":"10.4065\/76.1.22_bib3","first-page":"348a","article-title":"Epidemiological, diagnostic, therapeutic and prognostic aspects of essential thrombocythemia in a retrospective study of the GIMMC group in two thousand patients [abstract]","volume":"90","author":"Gugliotta","year":"1997","journal-title":"Blood"},{"key":"10.4065\/76.1.22_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1099-1069(199711)15:4<173::AID-HON610>3.0.CO;2-K","article-title":"Age and sex distributions of hematological malignancies in the UK","volume":"15","author":"McNally","year":"1997","journal-title":"Hematol Oncol"},{"key":"10.4065\/76.1.22_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0733-8627(20)30983-4","article-title":"Platelet count","volume":"4","author":"Hamilton","year":"1986","journal-title":"Emerg Med Clin North Am"},{"key":"10.4065\/76.1.22_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000205560","article-title":"Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis-a critical evaluation of clinical and histomorphological data","volume":"81","author":"Thiele","year":"1989","journal-title":"Acta Haematol"},{"key":"10.4065\/76.1.22_bib7","first-page":"517","article-title":"5q-Syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders? [letter]","volume":"9","author":"Koike","year":"1995","journal-title":"Leukemia"},{"key":"10.4065\/76.1.22_bib8","first-page":"1241","article-title":"Chronic myeloid leukemia of thrombocythemic onset: a CML subtype with distinct hematological and molecular features?","volume":"10","author":"Cervantes","year":"1996","journal-title":"Leukemia"},{"key":"10.4065\/76.1.22_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood"},{"key":"10.4065\/76.1.22_bib10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V91.2.616","article-title":"Acute myeloid leukemia and myelodysplastic syndromes following essential thrombo-cythemia treated with hydroxyurea: high proportion of cases with 17p deletion","volume":"91","author":"Sterkers","year":"1998","journal-title":"Blood"},{"key":"10.4065\/76.1.22_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0268-960X(97)90001-1","article-title":"New drugs in essential thrombocythemia and polycythemia vera","volume":"11","author":"Tefferi","year":"1997","journal-title":"Blood Rev"},{"key":"10.4065\/76.1.22_bib12","first-page":"29","article-title":"Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol"},{"key":"10.4065\/76.1.22_bib13","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.1995.00430110137015","article-title":"Outcome analysis of 34 pregnancies in women with essential thrombocythemia","volume":"155","author":"Beressi","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.4065\/76.1.22_bib14","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/1097-0142(19880315)61:6<1207::AID-CNCR2820610625>3.0.CO;2-4","article-title":"Controlled and uncontrolled thrombocytosis: its clinical role in essential thrombocythemia","volume":"61","author":"Lahuerta-Palacios","year":"1988","journal-title":"Cancer"},{"key":"10.4065\/76.1.22_bib15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.4065\/76.1.22_bib16","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3","article-title":"Thrombotic and hemorrhagic complications in essential thrombocythemia: a retrospective study of 103 patients","volume":"67","author":"Colombi","year":"1991","journal-title":"Cancer"},{"key":"10.4065\/76.1.22_bib17","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4065\/76.1.22_bib18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2141.1998.01021.x","article-title":"No treatment for low-risk thrombocythaemia: results from a prospective study","volume":"103","author":"Ruggeri","year":"1998","journal-title":"Br J Haematol"},{"key":"10.4065\/76.1.22_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","article-title":"Clinical course of essential thrombocythemia in 147 cases","volume":"66","author":"Fenaux","year":"1990","journal-title":"Cancer"},{"key":"10.4065\/76.1.22_bib20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand's disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"key":"10.4065\/76.1.22_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0002-9343(97)00239-8","article-title":"Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment","volume":"103","author":"Tefferi","year":"1997","journal-title":"Am J Med"},{"key":"10.4065\/76.1.22_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.1993.tb08272.x","article-title":"Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors","volume":"83","author":"Watson","year":"1993","journal-title":"Br J Haematol"},{"key":"10.4065\/76.1.22_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-2127.x","article-title":"Prevention and treatment of thrombotic complications in essential thrombocythaemia: efficacy and safety of aspirin","volume":"97","author":"van Genderen","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/76.1.22_bib24","first-page":"96","article-title":"The Third International Workshop on Chromosomes in Leukemia. Lund, Sweden, July 21-25, 1980, introduction","volume":"4","author":"Mittelman","year":"1981","journal-title":"Cancer Genet Cytogenet"},{"key":"10.4065\/76.1.22_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/77.3.353","article-title":"Acute leukemia as a natural sequel to primary thrombocythemia","volume":"77","author":"Geller","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/76.1.22_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000204260","article-title":"Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation-a brief review of recent literature","volume":"91","author":"Shibata","year":"1994","journal-title":"Acta Haematol"},{"key":"10.4065\/76.1.22_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6","article-title":"Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"52","author":"Nand","year":"1996","journal-title":"Am J Hematol"},{"key":"10.4065\/76.1.22_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00282-997-0011-x","article-title":"Is treatment with hydroxyurea leukomogenic in patients with essential thrombocythemia? an analysis of three new cases of leukaemic transformation and review of the literature","volume":"39","author":"Liozon","year":"1997","journal-title":"Hematol Cell Ther"},{"issue":"suppl 1","key":"10.4065\/76.1.22_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428199609074361","article-title":"Essential thrombocythemia and pregnancy","volume":"22","author":"Griesshammer","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.4065\/76.1.22_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<6::AID-AJH2>3.0.CO;2-V","article-title":"Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases","volume":"53","author":"Pagliaro","year":"1996","journal-title":"Am J Hematol"},{"key":"10.4065\/76.1.22_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0163-7258(97)82004-9","article-title":"Cytotoxic therapy and pregnancy","volume":"74","author":"Ebert","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.4065\/76.1.22_bib32","first-page":"814","article-title":"Treatment of essential thrombocythemia during pregnancy with interferon-alpha","volume":"87","author":"Delage","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.4065\/76.1.22_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1520-6661(199603\/04)5:2<74::AID-MFM5>3.0.CO;2-N","article-title":"Successful treatment of essential thrombocythemia in a pregnancy with recombinant interferon-alpha 2a","volume":"5","author":"Milano","year":"1996","journal-title":"J Matern Fetal Med"},{"key":"10.4065\/76.1.22_bib34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00007","article-title":"Factor V Leiden mutation as a risk factor for recurrent pregnancy loss","volume":"128","author":"Ridker","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.4065\/76.1.22_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<14::AID-AJH3>3.0.CO;2-9","article-title":"Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis","volume":"52","author":"Bucalossi","year":"1996","journal-title":"Am J Hematol"},{"key":"10.4065\/76.1.22_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90017-6","article-title":"Anagrelide, a therapy for thrombocythemic states: experience in 577 patients","volume":"92","author":"Anagrelide Study Group","year":"1992","journal-title":"Am J Med"},{"key":"10.4065\/76.1.22_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-2007-996123","article-title":"Interferon-alpha therapy in polycythemia vera and essential thrombocythemia","volume":"23","author":"Elliott","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.4065\/76.1.22_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0609.1994.tb01303.x","article-title":"Acute leukaemia after hydroxy-urea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications","volume":"52","author":"Weinfeld","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.4065\/76.1.22_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0950-3536(98)80038-3","article-title":"Treatment of polycythaemia vera and essential thrombocythaemia","volume":"11","author":"Tefferi","year":"1998","journal-title":"Baillieres Clin Haematol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611620752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611620752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:58:22Z","timestamp":1633010302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611620752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S0025619611620752"],"URL":"https:\/\/doi.org\/10.4065\/76.1.22","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}